Oral granulated Chinese herbal medicine (YXBCM01) plus topical calcipotriol for psoriasis vulgaris: study protocol for a double-blind, randomized placebo controlled trial
Discussion
The study will evaluate the feasibility of a randomized controlled trial investigating combined conventional and Chinese herbal medicine therapy for psoriasis vulgaris. The ingredients of YXBCM01 were selected based on literature, the expert opinion on herbal medicine and pre-clinical evidence, for instance Chinese herbal medicine possesses anti-inflammatory or antiproliferative properties.
Trial registration
Australian New Zealand Clinical Trials Registry ACTRN12614000493640.
Source: Trials - Category: Research Source Type: clinical trials
More News: Clinical Trials | Complementary Medicine | Dermatology | Herbs | Psoriasis | Research | Skin | Study | Taclonex